Literature DB >> 26121210

Predicting the Risk of a Second Basal Cell Carcinoma.

Joris A C Verkouteren1, Hilde Smedinga2, Ewout W Steyerberg2, Albert Hofman3, Tamar Nijsten4.   

Abstract

A third of basal cell carcinoma (BCC) patients will develop subsequent BCCs. We aimed to develop a simple model to predict the absolute risk of a second BCC. We observed 14,628 participants of Northern European ancestry from a prospective population-based cohort study. BCCs were identified using a linkage with the Dutch Pathology Registry (Pathological Anatomy National Automated Archive). Predictors for a second BCC included 13 phenotypic, lifestyle, and tumor-specific characteristics. The prediction model was based on the Fine and Gray regression model to account for the competing risk of death from other causes. Among 1,077 participants with at least one BCC, 293 developed a second BCC at a median of 3 years. Several well-known risk factors for a first BCC were not prognostic for a second BCC, whereas having more than one initial BCC was the strongest predictor. Discriminative ability at 3 years was reasonable (bootstrap validated c-index=0.65). Three groups were created, with 7, 12, and 28% risk of a second BCC within 3 years. We conclude that a combination of readily available clinical characteristics can reasonably identify patients at high risk of a second BCC. External validation and extension with stronger predictors is desirable to further improve risk prediction.

Entities:  

Mesh:

Year:  2015        PMID: 26121210     DOI: 10.1038/jid.2015.244

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  39 in total

1.  Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets.

Authors:  E W Steyerberg; M J Eijkemans; F E Harrell; J D Habbema
Journal:  Stat Med       Date:  2000-04-30       Impact factor: 2.373

2.  Development of a record linkage protocol for use in the Dutch Cancer Registry for Epidemiological Research.

Authors:  P A Van den Brandt; L J Schouten; R A Goldbohm; E Dorant; P M Hunen
Journal:  Int J Epidemiol       Date:  1990-09       Impact factor: 7.196

3.  Caffeine promotes ultraviolet B-induced apoptosis in human keratinocytes without complete DNA repair.

Authors:  Weinong Han; Mei Ming; Yu-Ying He
Journal:  J Biol Chem       Date:  2011-05-11       Impact factor: 5.157

4.  Coffee consumption and incident dementia.

Authors:  Saira Saeed Mirza; Henning Tiemeier; Renée F A G de Bruijn; Albert Hofman; Oscar H Franco; Jessica Kiefte-de Jong; Peter J Koudstaal; M Arfan Ikram
Journal:  Eur J Epidemiol       Date:  2014-08-26       Impact factor: 8.082

5.  Value of follow-up after treatment of basal cell carcinoma.

Authors:  E Epstein
Journal:  Arch Dermatol       Date:  1973-12

6.  Does intermittent sun exposure cause basal cell carcinoma? a case-control study in Western Australia.

Authors:  A Kricker; B K Armstrong; D R English; P J Heenan
Journal:  Int J Cancer       Date:  1995-02-08       Impact factor: 7.396

7.  Caffeine intake and risk of basal cell and squamous cell carcinomas of the skin in an 11-year prospective study.

Authors:  Kyoko Miura; Maria Celia B Hughes; Adèle C Green; Jolieke C van der Pols
Journal:  Eur J Nutr       Date:  2013-07-04       Impact factor: 5.614

Review 8.  A systematic review of worldwide incidence of nonmelanoma skin cancer.

Authors:  A Lomas; J Leonardi-Bee; F Bath-Hextall
Journal:  Br J Dermatol       Date:  2012-05       Impact factor: 9.302

9.  Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial.

Authors:  Martin A Weinstock; Kachiu C Lee; Mary-Margaret Chren; Kimberly Marcolivio
Journal:  J Am Acad Dermatol       Date:  2009-04-26       Impact factor: 11.527

10.  Trends in Basal cell carcinoma incidence rates: a 37-year Dutch observational study.

Authors:  Sophie C Flohil; Inge Seubring; Michelle M van Rossum; Jan-Willem W Coebergh; Esther de Vries; Tamar Nijsten
Journal:  J Invest Dermatol       Date:  2012-11-29       Impact factor: 8.551

View more
  10 in total

1.  November 2015 Snapshot Dx Quiz: Linking Science to Patient Care.

Authors:  Adam Wulkan; Mariya Miteva
Journal:  J Invest Dermatol       Date:  2015-11       Impact factor: 8.551

Review 2.  Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature.

Authors:  Alexandra M Haugh; Ching-Ni Njauw; Jeffrey A Bubley; Anna Elisa Verzì; Bin Zhang; Emily Kudalkar; Timothy VandenBoom; Kara Walton; Brian L Swick; Raj Kumar; Huma Q Rana; Sarah Cochrane; Shelley R McCormick; Christopher R Shea; Hensin Tsao; Pedram Gerami
Journal:  JAMA Dermatol       Date:  2017-10-01       Impact factor: 10.282

3.  Multiple Basal Cell Carcinomas in Immunocompetent Patients.

Authors:  Paola Savoia; Federica Veronese; Lara Camillo; Vanessa Tarantino; Ottavio Cremona; Elisa Zavattaro
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

4.  Clinical and pathological features associated with high-risk, multiple, and recurrent basal cell carcinomas: a retrospective cohort analysis from the Levantine coast of the Mediterranean Sea.

Authors:  Boutros Soutou; Carine Massih; Ghassan Sleilaty; Viviane Trak-Smayra; Marwan Nasr; Josiane Helou; Nabil Hokayem; Fady Ferran; Fadi H Sleilati; Farid Stéphan; Maya Halabi-Tawil; Roland Tomb
Journal:  Arch Dermatol Res       Date:  2022-01-21       Impact factor: 3.017

5.  Genome-Wide Association Studies of Multiple Keratinocyte Cancers.

Authors:  Luba M Pardo; Wen-Qing Li; Shih-Jen Hwang; Joris A C Verkouteren; Albert Hofman; André G Uitterlinden; Peter Kraft; Constance Turman; Jiali Han; Eunyoung Cho; Joanne M Murabito; Daniel Levy; Abrar A Qureshi; Tamar Nijsten
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

6.  Non-genetic and genetic predictors of a superficial first basal cell carcinoma.

Authors:  J A C Verkouteren; L M Pardo; A G Uitterlinden; T Nijsten
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-02-18       Impact factor: 6.166

7.  Healthcare utilization and management of actinic keratosis in primary and secondary care: a complementary database analysis.

Authors:  E C Noels; L M Hollestein; S van Egmond; M Lugtenberg; L P J van Nistelrooij; P J E Bindels; J van der Lei; R S Stern; T Nijsten; M Wakkee
Journal:  Br J Dermatol       Date:  2019-04-19       Impact factor: 9.302

8.  Predicting keratinocyte carcinoma in patients with actinic keratosis: development and internal validation of a multivariable risk-prediction model.

Authors:  S Tokez; M Alblas; T Nijsten; L M Pardo; M Wakkee
Journal:  Br J Dermatol       Date:  2020-02-26       Impact factor: 9.302

9.  Novel Insights for Patients with Multiple Basal Cell Carcinomas and Tumors at High-Risk for Recurrence: Risk Factors, Clinical Morphology, and Dermatoscopy.

Authors:  Dimitrios Sgouros; Dimitrios Rigopoulos; Ioannis Panayiotides; Zoe Apalla; Dimitrios K Arvanitis; Melpomeni Theofili; Sofia Theotokoglou; Anna Syrmali; Konstantinos Theodoropoulos; Georgia Pappa; Vasileia Damaskou; Alexander Stratigos; Alexander Katoulis
Journal:  Cancers (Basel)       Date:  2021-06-27       Impact factor: 6.639

10.  Developing a risk prediction model for keratinocyte carcinoma in patients with actinic keratosis.

Authors:  Y Kim; E Jorgenson; M M Asgari
Journal:  Br J Dermatol       Date:  2020-05-10       Impact factor: 9.302

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.